Long-term, heavy ketamine use is associated with memory problems, depression and anxiety. The drug may also cause ...

But there’s no denying that it's seen a surge of interest in recent years. Ketamine clinics—or treatment centers that offer ...

Mental Health Mondays are a series of segments airing every Monday in the month of May to honor Mental Health Awareness Month ...

Current FDA requirements for clinical trials call ... There’s precedent for that in the way that [esketamine] is being used in the US and worldwide.” Rosenbaum reported holding stock or ...

Medicare may cover Spravato (esketamine), an FDA-approved drug derived from ketamine that can help manage treatment-resistant depression. Despite lacking FDA approval for mental health treatment ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

S-ketamine, also known as esketamine (Spravato), is an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation or behavior. Esketamine ...

However, they may cover the FDA-approved nasal spray, Spravato, which contains a derivative of ketamine called esketamine. This article examines Medicare coverage for ketamine infusion ...